Effects of sequoyitol on expression of NADPH oxidase subunits p22 phox and p47 phox in rats with type 2 diabetic liver disease

Yaoxue Xuebao

Volumn 48, Issue 4, 2013, Pages 489-494

  Chen, Xiang Pan ^a   Yang, Jie Ren ^a   Li, Xian Wei ^a   Hao, Wei ^a   Liu, Yan ^a   Zhang, Jun Xiu ^a  

^a WANNAN MEDICAL COLLEGE   (China)

Author keywords

Diabetic liver disease; Oxidative stress; p22 phox; p47 phox; Sequoyitol; Type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HYDROGEN PEROXIDE; INOSITOL DERIVATIVE; INSULIN; NITRIC OXIDE; PROTEIN P22; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SEQUOYITOL; UNCLASSIFIED DRUG; 5-O-METHYL-MYO-INOSITOL; GLUCOSE BLOOD LEVEL; INOSITOL; MESSENGER RNA; NEUTROPHIL CYTOSOLIC FACTOR 1; P22-PHOX PROTEIN, RAT; STREPTOZOCIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIVER DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENETICS; LIVER; MALE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HYDROGEN PEROXIDE; HYPOGLYCEMIC AGENTS; INOSITOL; INSULIN; LIVER; LIVER DISEASES; MALE; NADPH OXIDASE; NITRIC OXIDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STREPTOZOCIN;

EID: 84878985670     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism [J]. Diabetes, 2005, 54: 1615-1625. (Pubitemid 40770750)
2. Wang YY, Li GF, Wang T. Sequoyitol in the distribution of plant species [J]. Pharm Today, 2008, 17: 70-74.
3. Sun MJ, Wang T. Used for diabetes prevention and treatment of sequoyitol and sequoyitol plant extracts: CN, 1706369 [P]. 2005-12-14.
4. Liang JY, Wu FH, Bao GH. A kind of prevention and cure of diabetes with plant extracts and its preparation method and drug use: CN, 1488344 [P]. 2004-4-14.
5. Liang JY, Wu FH, Bao GH. A natural compound useful for treating diabetes, its preparation and use: EP, 1559703 [P]. 2004-05-13.
6. Richard EO, William RS. Pinitol and derivatives thereof for the treatment of metabolic disorders: US, 5827896 [P]. 1998-10-27.
7. Li GW, Pan XR, Lillioja S, et al. A new insulin-sensitivity index for the population-based study [J]. Chin J Intern Med, 1993, 32: 656-660.
8. Harrison SA. Liver disease in patients with diabetes mellitus [J]. Clin Gastroenterol, 2006, 40: 68-76. (Pubitemid 44378080)
9. Younossi ZM, Gramlich T, Liu YC, et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations [J]. Mod Pathol, 1998, 11: 560-565. (Pubitemid 28280720)
10. Gawrieh S, Knoedler DM, Saeian K, et al. Effects of interventions on intra- and inter observer agreement on interpretation of nonalcoholic fatty liver disease histology [J]. Ann Diagn Pathol, 2011, 15: 19-24.
11. Hossain N, Afendy A, Stepanova M, et al. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease [J]. Clin Gastroenterol Hepatol, 2009, 7: 1224-1229.
12. Czaja MJ, Liu H, Wang Y. Oxidant-induced hepatocyte injury from menadione is regulated by ERK and AP-1 signaling [J]. Hepatology, 2003, 37: 1405-1413. (Pubitemid 36667321)
13. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress [J]. Mol Aspects Med, 2000, 21: 49-98. (Pubitemid 30642764)
14. Victor VM, Rocha M, Herance R, et al. Oxidative stress and mitochondrial dysfunction in type 2 diabetes [J]. Curr Pharm Des, 2011, 17: 3947-3958.
15. Chen HY, Wang JH, Geng M, et al. Protective effect of extract of Apocynum venetum on kidneys of streptozotocin-induced diabetic rats [J]. Acta Pharm Sin, 2010, 45: 26-30.
16. Haddad JJ, Harb HL. L-gamma-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensors [J]. Mol Immunol, 2005, 42: 987-1014.